Alaunos Therapeutics | ZIOP - Debt


Alaunos Therapeutics reported $10.99M in Debt for its fiscal quarter ending in March of 2023.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 54.59B 1.62B Sep/2025
AstraZeneca USD 32.63B 207M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
Bioline Rx USD 11.38M 1.22M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Celltrion KRW 171.09B 2.05T Jun/2025
Corcept Therapeutics USD 6.36M 247K Sep/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Curis USD 0 0 Jun/2022
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Incyte USD 40.41M 855K Dec/2025
Intrexon USD 0 13.82M Jun/2024
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
J&J USD 45.8B 4.97B Sep/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Karyopharm Therapeutics USD 264.09M 39.31M Sep/2024
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Novartis USD 32.64B 1.37B Jun/2025
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 60.85B 78M Sep/2025
Pharma Mar EUR 51.4M 405K Jun/2025
PTC Therapeutics USD 286.32M 306K Sep/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
TG Therapeutics USD 245.34M 8.38M Sep/2025
Tilray USD 640.95M 35.17M Jun/2022
Verastem USD 66.79M 26.7M Sep/2024
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025